Detection of Circulating Tumor Cells in Patients with Breast, Prostate, Pancreatic, Colon and Melanoma Cancer: A Blinded Comparative Study Using Healthy Donors — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Detection of Circulating Tumor Cells in Patients with Breast, Prostate, Pancreatic, Colon and Melanoma Cancer: A Blinded Comparative Study Using Healthy Donors
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
,
Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
1 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
2 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
3 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
4 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
5 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
6 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
7 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
8 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
9 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
10 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
11 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
12 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
13 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
14 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
15 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
16 Research Genetic Cancer Centre Ltd. (R.G.C.C. Ltd.), Florina, Greece
Cancer is a diverse disease characterized by abnormal cell growth and the ability to invade or spread to other parts of the body. Because the yearly cancer rate is increasing, an important area for cancer researchers is to improve the ability to detect and treat cancer early. The current study analyzes the potential of flow cytometry to be used to detect circulating tumor cells (CTCs) in patients with various cancer types and stages. CTCs are cells that have detached from the primary tumor and entered the blood stream in the process of metastasizing to other organs. To determine the accuracy of flow cytometry in detecting CTCs, a comparative study was performed on healthy donors. In this study, blood samples from patients with breast, prostate, pancreatic, colon and skin cancer were analyzed and compared with healthy donors. The data were collected and analyzed statistically with receiver operating characteristic curve analysis. The results indicate that CTCs can be detected in over 83% of the cancer patients and therefore may be a promising method for diagnosing cancer.
Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014) Cancer Statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 9-29. http://dx.doi.org/10.3322/caac.21208
Chaffer, C.L. and Weinberg, R.A. (2011) A Perspective on Cancer Cell Metastasis. Science, 331, 1559-1564. http://dx.doi.org/10.1126/science.1203543
Chambers, A.F., Groom, A.C. and MacDonald, I.C. (2002) Dissemination and Growth of Cancer Cells in Metastatic Sites. Nature Reviews Cancer, 2, 563-572. http://dx.doi.org/10.1038/nrc865
Williams, S.C. (2013) Circulating Tumor Cells. Proceedings of the National Academy of Sciences of the USA, 110, 4861. http://dx.doi.org/10.1073/pnas.1304186110
Plaks, V., Koopman, C.D. and Werb, Z. (2013) Cancer. Circulating Tumor Cells. Science, 341, 1186-1188. http://dx.doi.org/10.1126/science.1235226
Miller, M.C., Doyle, G.V. and Terstappen, L.W. (2010) Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. Journal of Oncology, 2010, Article ID: 617421. http://dx.doi.org/10.1155/2010/617421
Smirnov, D.A., Zweitzig, D.R., Foulk, B.W., Miller, M.C., Doyle, G.V., Pienta, K.J., Meropol, N.J., Weiner, L.M., Cohen, S.J., Moreno, J.G., et al. (2005) Global Gene Expression Profiling of Circulating Tumor Cells. Cancer Research, 65, 4993-4997. http://dx.doi.org/10.1158/0008-5472.CAN-04-4330
Stott, S.L., Hsu, C.H., Tsukrov, D.I., Yu, M., Miyamoto, D.T., Waltman, B.A., Rothenberg, S.M., Shah, A.M., Smas, M.E., Korir, G.K., et al. (2010) Isolation of Circulating Tumor Cells Using a Microvortex-Generating Herringbone-Chip. Proceedings of the National Academy of Sciences of the USA, 107, 18392-18397. http://dx.doi.org/10.1073/pnas.1012539107
Gredelj-Simec, N., Jelic-Puskaric, B., Ostojic, A., Siftar, Z., Fiala, D., Kardum-Skelin, I., Vrhovac, R. and Jaksic, B. (2011) Diagnostic and Prognostic Significance of CD45 Cell Surface Antigen Expression in Hematologic Malignancies with Main Focus on Acute Leukemias. Acta Medica Croatica, 65, 45-52.
Liu, L. and Shi, G.P. (2012) CD31: Beyond a Marker for Endothelial Cells. Cardiovascular Research, 94, 3-5. http://dx.doi.org/10.1093/cvr/cvs108
Sorenson, S.C., Asch, B.B., Connolly, J.L., Burstein, N.A. and Asch, H.L. (1987) Structural Distinctions among Human Breast Epithelial Cells Revealed by the Monclonal Antikeratin Antibodies AE1 and AE3. The Journal of Pathology, 153, 151-162. http://dx.doi.org/10.1002/path.1711530208
Gentile, A., Trusolino, L. and Comoglio, P.M. (2008) The Met Tyrosine Kinase Receptor in Development and Cancer. Cancer and Metastasis Reviews, 27, 85-94. http://dx.doi.org/10.1007/s10555-007-9107-6
Hollingsworth, M.A. and Swanson, B.J. (2004) Mucins in Cancer: Protection and Control of the Cell Surface. Nature Reviews Cancer, 4, 45-60. http://dx.doi.org/10.1038/nrc1251
Maria, T., Panagiotis, A., Marina, C., Eleni, K., Ioanna, V., Georgia, M. and Ioannis, P. (2014) How Prostate-Specific Membrane Antigen Level May Be Correlated with Stemness in Prostate Cancer Stem Cell-Like Cell Populations? Journal of Cancer Research and Therapeutics, 10, 133-141. http://dx.doi.org/10.4103/0973-1482.131461
Radford, K.J., Thorne, R.F. and Hersey, P. (1996) CD63 Associates with Transmembrane 4 Superfamily Members, CD9 and CD81, and with Beta 1 Integrins in Human Melanoma. Biochemical and Biophysical Research Communications, 222, 13-18. http://dx.doi.org/10.1006/bbrc.1996.0690
Linden, A. (2006) Measuring Diagnostic and Predictive Accuracy in Disease Management: An Introduction to Receiver Operating Characteristic (ROC) Analysis. Journal of Evaluation in Clinical Practice, 12, 132-139. http://dx.doi.org/10.1111/j.1365-2753.2005.00598.x
Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O’Briant, K.C., Allen, A., et al. (2008) Circulating microRNAs as Stable Blood-Based Markers for Cancer Detection. Proceedings of the National Academy of Sciences of the United States of America, 105, 10513-10518. http://dx.doi.org/10.1073/pnas.0804549105
Toloudi, M., Apostolou, P., Chatziioannou, M. and Papasotiriou, I. (2011) Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their Value. Case Reports in Oncology, 4, 44-54. http://dx.doi.org/10.1159/000324403
Pilo, A., Zucchelli, G.C., Cohen, R., Bizollon, C.A., Cappelli, G., Cianetti, A., Gion, M., Piffanelli, A. and Bombardieri, E. (1995) Comparison of Immunoassays for Tumor Markers CA 19-9, CA 15-3 and CA 125: Data from an International Quality Assessment Scheme. Tumori, 81, 117-124.
Duffy, M.J. (2001) Clinical Uses of Tumor Markers: A Critical Review. Critical Reviews in Clinical Laboratory Sciences, 38, 225-262. http://dx.doi.org/10.1080/20014091084218
Tibbe, A.G., Miller, M.C. and Terstappen, L.W. (2007) Statistical Considerations for Enumeration of Circulating Tumor Cells. Cytometry Part A, 71, 154-162. http://dx.doi.org/10.1002/cyto.a.20369
Hermann, P.C., Huber, S.L., Herrler, T., Aicher, A., Ellwart, J.W., Guba, M., Bruns, C.J. and Heeschen, C. (2007) Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer. Cell Stem Cell, 1, 313-323. http://dx.doi.org/10.1016/j.stem.2007.06.002
Kalluri, R. and Weinberg, R.A. (2009) The Basics of Epithelial-Mesenchymal Transition. Journal of Clinical Investigation, 119, 1420-1428. http://dx.doi.org/10.1172/JCI39104
Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., et al. (2008) The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell, 133, 704-715. http://dx.doi.org/10.1016/j.cell.2008.03.027
Riethdorf, S., Fritsche, H., Muller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Janicke, F., et al. (2007) Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the Cell Search System. Clinical Cancer Research, 13, 920-928. http://dx.doi.org/10.1158/1078-0432.CCR-06-1695
Marrinucci, D., Bethel, K., Lazar, D., Fisher, J., Huynh, E., Clark, P., Bruce, R., Nieva, J. and Kuhn, P. (2010) Cytomorphology of Circulating Colorectal Tumor Cells: A Small Case Series. Journal of Oncology, 2010, Article ID: 861341. http://dx.doi.org/10.1155/2010/861341
Meng, S., Tripathy, D., Frenkel, E.P., Shete, S., Naftalis, E.Z., Huth, J.F., Beitsch, P.D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) Circulating Tumor Cells in Patients with Breast Cancer Dormancy. Clinical Cancer Research, 10, 8152-8162. http://dx.doi.org/10.1158/1078-0432.CCR-04-1110
Allard, W.J., Matera, J., Miller, M.C., Repollet, M., Connelly, M.C., Rao, C., Tibbe, A.G., Uhr, J.W. and Terstappen, L.W. (2004) Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but Not in Healthy Subjects or Patients with Nonmalignant Diseases. Clinical Cancer Research, 10, 6897-6904. http://dx.doi.org/10.1158/1078-0432.CCR-04-0378
Momburg, F., Moldenhauer, G., Hammerling, G.J. and Moller, P. (1987) Immunohistochemical Study of the Expression of a Mr 34,000 Human Epithelium-Specific Surface Glycoprotein in Normal and Malignant Tissues. Cancer Research, 47, 2883-2891.
Pachmann, K., Camara, O., Kavallaris, A., Krauspe, S., Malarski, N., Gajda, M., Kroll, T., Jorke, C., Hammer, U., Altendorf-Hofmann, A., et al. (2008) Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse. Journal of Clinical Oncology, 26, 1208-1215. http://dx.doi.org/10.1200/JCO.2007.13.6523
Cristofanilli, M. (2009) The Biological Information Obtainable from Circulating Tumor Cells. The Breast, 18, S38-S40. http://dx.doi.org/10.1016/s0960-9776(09)70270-x
Sterzynska, K., Kempisty, B., Zawierucha, P. and Zabel, M. (2012) Analysis of the Specificity and Selectivity of Anti-EpCAM Antibodies in Breast Cancer Cell Lines. Folia Histochemica et Cytobiologica, 50, 534-541. http://dx.doi.org/10.5603/FHC.2012.0075
Moncada, D.M., Kammanadiminti, S.J. and Chadee, K. (2003) Mucin and Toll-Like Receptors in Host Defense against Intestinal Parasites. Trends in Parasitology, 19, 305-311. http://dx.doi.org/10.1016/S1471-4922(03)00122-3
Wang, M.X., Earley Jr., J.J., Shields, J.A. and Donoso, L.A. (1992) An Ocular Melanoma-Associated Antigen. Molecular Characterization. Archives of Ophthalmology, 110, 399-404. http://dx.doi.org/10.1001/archopht.1992.01080150097036
Iida, J., Skubitz, A.P., McCarthy, J.B. and Skubitz, K.M. (2005) Protein Kinase Activity Is Associated with CD63 in Melanoma Cells. Journal of Translational Medicine, 3, 42. http://dx.doi.org/10.1186/1479-5876-3-42
O’Keefe, D.S., Bacich, D.J. and Heston, W.D. (2004) Comparative Analysis of Prostate-Specific Membrane Antigen (PSMA) versus a Prostate-Specific Membrane Antigen-Like Gene. Prostate, 58, 200-210. http://dx.doi.org/10.1002/pros.10319
Bardelli, A., Corso, S., Bertotti, A., Hobor, S., Valtorta, E., Siravegna, G., Sartore-Bianchi, A., Scala, E., Cassingena, A., Zecchin, D., et al. (2013) Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. Cancer Discovery, 3, 658-673. http://dx.doi.org/10.1158/2159-8290.CD-12-0558